GNE-8505
Product Specifications
UNSPSC Description
GNE-8505 is an orally available inhibitor of Dual leucine zipper kinase (DLK)[1].
Target Antigen
MAP3K
Type
Reference compound
Related Pathways
MAPK/ERK Pathway
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/gne-8505.html
Purity
99.86
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
FC(F)(F)C1=CC(C2=NN(C([C@@H]3[C@]4([H])[C@@]3([H])CN(C5COC5)C4)=C2)CC6CC6)=CN=C1N
Molecular Weight
419.44
References & Citations
[1]Le Pichon CE, et al. Loss of dual leucine zipper kinase signaling is protective in animal models of neurodegenerative disease. Sci Transl Med. 2017 Aug 16;9(403). pii: eaag0394.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-114332/GNE-8505-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-114332/GNE-8505-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
1620573-48-9
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1225812-01 0.02 mg (E-Coli)
Recombinant Saguinus midas niger Beta-2-microglobulin (B2M)
Ask
View Details MBS1225812-02 0.1 mg (E-Coli)
Recombinant Saguinus midas niger Beta-2-microglobulin (B2M)
Ask
View Details MBS1225812-03 0.02 mg (Yeast)
Recombinant Saguinus midas niger Beta-2-microglobulin (B2M)
Ask
View Details